Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer

被引:0
|
作者
Koie, T. [1 ]
Yamamoto, H. [1 ]
Okamoto, A. [1 ]
Hatakeyama, S. [1 ]
Momose, A. [1 ]
Iwabuchi, I. [1 ]
Yoneyama, T. [1 ]
Hashimoto, Y. [1 ]
Kamimura, N. [1 ]
Ohyama, C. [1 ]
Saijo, Y. [1 ]
机构
[1] Hirosaki Univ, Sch Med, Hirosaki, Aomori 036, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16100
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
    Ohyama, Chikara
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 3 - 4
  • [2] Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study
    Okabe, Ko
    Shindo, Tetsuya
    Maehana, Takeshi
    Nishiyama, Naotaka
    Hashimoto, Kohei
    Itoh, Naoki
    Takahashi, Atsushi
    Taguchi, Keisuke
    Tachiki, Hitoshi
    Tanaka, Toshiaki
    Masumori, Naoya
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (10) : 934 - 941
  • [3] CISPLATIN AND GEMCITABINE NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTITUTE EXPERIENCE
    Verri, Elena
    Mascia, Roberta
    Rocca, Maria Cossu
    Aurilio, Gaetano
    Cullura, Daniela
    Musi, Gennaro
    Cozzi, Gabriele
    Di Trapani, Ettore
    Russo, Andrea
    De Cobelli, Ottavio
    Nole, Franco
    [J]. ANTICANCER RESEARCH, 2018, 38 (04) : 2515 - 2518
  • [4] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [5] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [6] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Hattori, Yuto
    Fujiwara, Tasuku
    Hagimoto, Hiroki
    Kokubun, Hidetoshi
    Murata, Shiori
    Makita, Noriyuki
    Abe, Yohei
    Kubota, Masashi
    Tohi, Yoichiro
    Tsutsumi, Naofumi
    Shibasaki, Noboru
    Inoue, Koji
    Kawakita, Mutsushi
    Yamasaki, Toshinari
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2024,
  • [7] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    [J]. EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [8] Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meleis, Laura
    Moore, Russell
    Inman, Brant A.
    Harrison, Michael R.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 330 - 337
  • [9] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
    Koie, Takuya
    Okamoto, Teppei
    Imanishi, Kengo
    Sugiyama, Naoki
    Kudoh, Shigemasa
    Mori, Kazuyuki
    Tachiwada, Tokushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kamimura, Noritaka
    Ohyama, Chikara
    Suzuki, Yuichiro
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
  • [10] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Nezu, Masahiko
    Itoh, Kuniaki
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 310 - 317